Core Laboratories (CLB) Shares Outstanding (Weighted Average) (2022 - 2026)
Core Laboratories filings provide 5 years of Shares Outstanding (Weighted Average) readings, the most recent being $46.1 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Weighted Average) fell 1.5% to $46.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $46.1 million, a 1.5% decrease, with the full-year FY2025 number at $46.4 million, down 1.0% from a year prior.
- Shares Outstanding (Weighted Average) hit $46.1 million in Q1 2026 for Core Laboratories, down from $46.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.9 million in Q3 2024 to a low of $46.1 million in Q1 2026.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $46.7 million (2023), compared with a mean of $46.6 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.81% in 2023 and later fell 1.5% in 2026.
- Core Laboratories' Shares Outstanding (Weighted Average) stood at $46.3 million in 2022, then increased by 0.75% to $46.7 million in 2023, then increased by 0.46% to $46.9 million in 2024, then fell by 1.0% to $46.4 million in 2025, then dropped by 0.76% to $46.1 million in 2026.
- The last three reported values for Shares Outstanding (Weighted Average) were $46.1 million (Q1 2026), $46.4 million (Q4 2025), and $46.3 million (Q3 2025) per Business Quant data.